I'm sure this is totally an industry-driven move. Other insurers are PO'd b/c the UHC and Harvard Pilgrim policies have been used in appeals for something they don't want to pay for. Add that to UHC maybe noticing hey, there are a lot more of these kids getting dx'd and needing treatment now and it's getting a bit expensive to do the right thing, and those guys don't play fair so why should we?
Time for a media blitz, maybe? My angle would be:
UHC has covered this as a proven treatment for the condition for X years. There have been no recent studies refuting the evidence UHC's previous policy was based upon and there is no new evidence in the medical literature suggesting the previous results were inaccurate. In fact, support for its use in the treatment of this condition has only increased in the past year, with the NIMH (the govt org overseeing PANDAS research-- important to mention b/c many major health insurers say they consult/follow govt health org's recommendations) recommending at as one of the standard of care treatments for this rare, pediatric condition. Specialists in this condition who treat patients in their clinical practices consider this the standard treatment for the condition (insert expert PANDAS doc quotes here).
The dramatic improvement Dr. Expert has seen in her/his clinical practice with the use of IVIG for PANDAS is echoed by the families whose lives have been changed by this difficult illness, and restored through treatment with IVIG-- many of those cases covered by UHC and carried out safely and effectively by the skilled providers in its network. Take Little Johnny for example... insert compelling story of one of our kids--preferably one whose treatment was funded by UHC. After sharing Johnny's story-- finishing of course with the triumphant return to his former self thanks to that UHC paid IVIG (something many of us have experienced) be sure to mention that Johnny and his family are terrified what this new, baseless policy change by UHC might mean for Johnny should he ever fall into the grips of another serious PANDAS episode following an infectious illness-- the type that are common among children his age and to which he may be exposed any given day just by going to school or playing with his friends.
Doctors and parents speculate that UHC, which they'd previously thought of as ethical and honest due to its coverage policy that privileged the medical evidence and patients over the cost, may be caving to industry pressure as other insurance companies have been facing increasing pressure to cover the treatment for this condition and being asked to defend their denials of coverage, particularly when other leading insurers, such as UHC and Harvard Pilgrim, as well as the country of Canada, have medical policies that consider IVIG a proven treatment for PANDAS.
Then add something about why treatments for peds and rare conditions don't get FDA approval (financial) and how FDA approval does not apply to the practice of medicine. And quote AAP's paper on peds off-label prescribing/use.
We asked UHC and they said, "CYA CYA CYA with some jargon thrown in to sound super official and medical and above all y'all..." Dr PANDAS expert responded to this statement by UHC, "Despite UHC's fancy-word sh*& flinging, the fact remains that the evidence still supports this treatment for PANDAS. None of that has changed since UHC last revised its policy. And UHC has not satisfactorily explained how it reached the conclusion that it's previous policy was incorrect, and if it was incorrect, how it happened that its policy supported the use of an unproven treatment, and covered it for numerous children based on some error on UHC's part, over a period of several years."
Then finish by returning to Johnny-- For now, Johnny's parents are just grateful that he's well, and are hoping they'll never face a day that they lose him to another bout with his PANDAS, but are unable to afford the treatment he needs to bring him back to them.
Or something roughly like that...